Hemochromatosis: Genetics and pathophysiology

被引:90
作者
Beutler, E [1 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
来源
ANNUAL REVIEW OF MEDICINE | 2006年 / 57卷
关键词
hepcidin; HFE; iron; ferroportin; penetrance;
D O I
10.1146/annurev.med.57.121304.131310
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A number of genetic disorders can result in the accumulation of excess iron in the body. These causes of hereditary hemochromatosis include defects in genes encoding HFE, transferrin receptor 2, ferroportin, hepcidin, and hemajuvelin. Hepcidin, with its cognate receptor, ferroportin, has emerged as a central regulator of iron homeostasis; all of the known causes of hemochromatosis appear to prevent this system from functioning normally. The most common form of primary hemochromatosis is that caused by C282Y mutation of the HFE gene. This mutation is most prevalent among Northern Europeans. Although the frequency of the homozygous genotype is approximately 5 per 1000, the disease itself is quite rare because the clinical penetrance of the genotype is very low.
引用
收藏
页码:331 / 347
页数:17
相关论文
共 110 条
  • [1] Population screening for hemochromatosis: A comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors
    Adams, PC
    Kertesz, AE
    McLaren, CE
    Barr, R
    Bamford, A
    Chakrabarti, S
    [J]. HEPATOLOGY, 2000, 31 (05) : 1160 - 1164
  • [2] Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis
    Aguilar-Martinez, P
    Esculié-Coste, C
    Bismuth, M
    Giansily-Blaizot, M
    Larrey, D
    Schved, JF
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2001, 27 (01) : 290 - 293
  • [3] Decreased liver hepcidin expression in the Hfe knockout mouse
    Ahmad, KA
    Ahmann, JR
    Migas, MC
    Waheed, A
    Britton, RS
    Bacon, BR
    Sly, WS
    Fleming, RE
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2002, 29 (03) : 361 - 366
  • [4] Ajioka RS, 2003, BLOOD, V101, P3358, DOI 10.1182/blood-2003-01-0040
  • [5] Haplotype analysis of hemochromatosis: Evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes
    Ajioka, RS
    Jorde, LB
    Gruen, JR
    Yu, P
    Dimitrova, D
    Barrow, J
    Radisky, E
    Edwards, CQ
    Griffen, LM
    Kushner, JP
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (06) : 1439 - 1447
  • [6] Hemochromatosis mutations in the general population: iron overload progression rate
    Andersen, RV
    Tybjaerg-Hansen, A
    Appleyard, M
    Birgens, H
    Nordestgaard, BG
    [J]. BLOOD, 2004, 103 (08) : 2914 - 2919
  • [7] Åsberg A, 2001, SCAND J GASTROENTERO, V36, P1108
  • [8] Persons with screening-detected haemochromatosis:: as healthy as the general population?
    Åsberg, A
    Hveem, K
    Krüger, O
    Bjerve, KS
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (06) : 719 - 724
  • [9] Benefit of population-based screening for phenotypic hemochromatosis in young men
    Åsberg, A
    Tretli, S
    Hveem, K
    Bjerve, KS
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (10) : 1212 - 1219
  • [10] BARTOLONI S, 1984, HEPATO-GASTROENTEROL, V31, P215